Mode
Text Size
Log in / Sign up
N/A Completed N=17 Randomized Single-blind Treatment

Clinical Validation Study of Comfilcon A Multifocal Toric Contact Lenses

Source: ClinicalTrials.gov NCT03417557 ↗
Enrolled (actual)
17
Serious AEs
0.0%
Results posted
May 2020
Primary outcomePrimary: Visual Acuity — -0.01; -0.03; -0.05; 0.06 logMAR

Summary

This is a study to evaluate the clinical performance and subjective acceptance of an investigational contact lens (test), compared to a marketed lens (control) in an in-office setting.

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Acuity
-0.01; -0.03; -0.05; 0.06; 0.02; 0.13
SECONDARY
Subjective Assessment of Visual Performance: Distance Day-time Navigation Tasks for Vision Quality and Clarity
91; 79
SECONDARY
Subjective Assessment of Visual Performance: Intermediate / Computer Task for Vision Quality and Clarity
87; 82
SECONDARY
Subjective Assessment of Visual Performance: Near Vision for Vision Quality and Clarity
84; 79

Eligibility Criteria

Inclusion Criteria

  • Has had a self-reported oculo-visual examination in the last two years.
  • Is between ages 40-75 years, inclusive and has full legal capacity to volunteer.
  • Has read and understood the information consent letter. Is willing and able to follow instructions and maintain the appointment schedule.
  • Is able to participate in Parts A and B related to this work.
  • Has a contact lens spherical prescription between +10.00 to 10.00D (inclusive).
  • Has an Add component to their spectacle refraction (between +0.75 and +2.50DS).
  • Has astigmatism between of -0.75 and -5.75DC (based on the calculated ocular refraction) in each eye.
  • Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/25 best-corrected.
  • Currently wears soft contact lenses.
  • Has clear corneas and no active ocular disease.
  • Has not worn lenses for at least 12 hours before the examination.

Exclusion Criteria

A person will be excluded from the study if he/she:

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03417557). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search